menu search

Helius medical technologies to present at the 2023 interdisciplinary association of functional neuroscience and rehabilitation conference

-- Presentation to educate on Portable Neuromodulation Stimulator (PoNS®) Therapy, highlighting the differentiation from other neuromodulation techno...

September 13, 2023, 7:05 am

Promis neurosciences to present at the h.c. wainwright 25th annual global investment conference

TORONTO, Ontario and CAMBRIDGE, Massachusetts, Sept. 06, 2023 (GLOBE NEWSWIRE) -- ProMIS neurosciences ...

September 6, 2023, 12:18 pm

Minerva neurosciences: there's probably time for one more rally

Minerva neurosciences has raised $20M through a private placement at a premium to market prices. Boehri...

August 23, 2023, 4:05 am

Minerva neurosciences reports 2023 second quarter financial results and business updates

BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Minerva neurosciences, Inc. (Nasdaq: NERV), a cli...

August 1, 2023, 11:30 am

Here's why minerva neurosciences (nerv) is a great 'buy the bottom' stock now

Minerva neurosciences (NERV) appears to have found support after losing some value lately, as indicated...

June 9, 2023, 10:57 am

Minerva neurosciences: up about 250 percent since april with an fda catalyst ahead

NERV has once again run on the submission of an NDA for roluperidone for the treatment of negative symptoms in schizophrenia. There will be no Refusal...

May 19, 2023, 5:34 pm

Minerva neurosciences reports 2023 first quarter financial results and business updates

Company to host conference call today at 8:30 a.m. ET BURLINGTON, Mass., May 15, 2023 (GLOBE NEWSWIRE) — Minerva ...

May 15, 2023, 11:30 am

Eli lilly releases positive results on latest disease modifying therapeutic for alzheimer's disease, highlighting need for cognetivity's cognica platform

The news highlights the urgent need for more consistent, wide scale detection of the disease at an early stage Vancouver, British Columbia--(Newsfile ...

May 9, 2023, 9:23 am

Minerva neurosciences to report first quarter 2023 financial results and business updates on may 15, 2023

BURLINGTON, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Minerva neurosciences, Inc. (Nasdaq: NERV), a clin...

May 8, 2023, 8:30 am

Promis neurosciences submits ind application for alzheimer's treatment

ProMIS neurosciences (TSX:PMN) told investors it has submitted an Investigational New Drug (IND) appli...

April 10, 2023, 9:11 am

Minerva neurosciences, inc. (nerv) q4 2022 earnings call transcript

Minerva neurosciences, Inc. (NASDAQ:NERV ) Q4 2022 Earnings Conference Call March 8, 2023 8:30 AM ET Co...

March 8, 2023, 11:31 am

Minerva neurosciences, inc. (nerv) q3 2022 earnings call transcript

Minerva neurosciences, Inc. (NASDAQ:NERV ) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ET...

November 9, 2022, 10:02 am

Billionaire steven cohen just made a big bet on minerva neurosciences (nerv) stock

Shares of Minerva neurosciences (NASDAQ: NERV ) are soaring higher by over 70%  following a purchase b...

August 24, 2022, 3:45 pm

Promis neurosciences (pmn) stock surged 32.33% in nasdaq debut: details

The shares of ProMIS neurosciences Inc. (Nasdaq: PMN) surged 32.33% in its Nasdaq debut. These are some...

July 9, 2022, 5:14 am

Minerva outlines next steps for us application for schizophrenia candidate

Minerva neurosciences Inc (NASDAQ: NERV) received the official meeting minutes from the Type C meetin...

April 7, 2022, 1:01 pm

Minerva neurosciences (nerv) reports q4 loss, misses revenue estimates

Minerva neurosciences (NERV) delivered earnings and revenue surprises of 40% and 100%, respectively, fo...

March 1, 2022, 10:44 am

Minerva neurosciences (nerv) reports q4 loss, misses revenue estimates

Minerva neurosciences (NERV) delivered earnings and revenue surprises of 40% and 100%, respectively, fo...

March 1, 2022, 10:44 am

Minerva neurosciences (nerv) reports q4 loss, misses revenue estimates

Minerva neurosciences (NERV) delivered earnings and revenue surprises of 40% and 100%, respectively, fo...

March 1, 2022, 10:44 am

Enveric biosciences collaborates with university of calgary to establish clinical trial for evm-101 in cancer related distress

Enveric Biosciences (NASDAQ:ENVB) said it is working with the University of Calgary's Hotchkiss Brain Institute (HBI), a leading ...

February 17, 2022, 9:06 am

Enveric biosciences collaborates with university of calgary to establish clinical trial for evm-101 in cancer related distress

Enveric Biosciences (NASDAQ:ENVB) said it is working with the University of Calgary's Hotchkiss Brain Institute (HBI), a leading ...

February 17, 2022, 9:06 am


Search within

Pages Search Results: